Publicaciones en colaboración con investigadores/as de Hospital General Universitario de Alicante (16)

2020

  1. miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk

    Leukemia, Vol. 34, Núm. 10, pp. 2648-2659

2010

  1. CALU A29809G polymorphism in coronary atherothrombosis: Implications for coronary calcification and prognosis

    Annals of Medicine, Vol. 42, Núm. 6, pp. 439-446

  2. Plasma levels of Von Willebrand factor are increased in patients with hypertrophic cardiomyopathy

    Thrombosis Research, Vol. 126, Núm. 1

  3. Synergism between factor XII -4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction

    Thrombosis and Haemostasis

2009

  1. Antithrombin Cambridge ll (A384S) supports a role for antithrombin deficiency in arterial thrombosis

    Thrombosis and Haemostasis, Vol. 101, Núm. 3, pp. 483-486

2008

  1. Factor VII -323 decanucleotide D/I polymorphism in atrial fibrillation: Implications for the prothrombotic state and stroke risk

    Annals of Medicine, Vol. 40, Núm. 7, pp. 553-559

2007

  1. Prognostic value of annexin A5-1 C/T polymorphism in a long term follow-up after premature myocardial infarction [2]

    Journal of Thrombosis and Haemostasis

  2. The genetic interaction between VKORC1 c1173t and calumenin a29809g modulates the anticoagulant response of acenocoumarol

    Journal of Thrombosis and Haemostasis, Vol. 5, Núm. 8, pp. 1701-1706

2006

  1. Fluctuations in coagulation activity among patients with atrial fibrillation who are stably anticoagulated

    Future Cardiology, Vol. 2, Núm. 2, pp. 197-203

2005

  1. A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction

    Journal of the American College of Cardiology, Vol. 45, Núm. 1, pp. 25-29

  2. Five prothrombotic polymorphisms and the prevalence of premature myocardial infarction

    Haematologica, Vol. 90, Núm. 3, pp. 421-423

2004

  1. Effect of factor VII -323 Del/Ins polymorphism on the daily variability of factor VIIc and INR in steady anticoagulated patients with acenocoumarol [3]

    Journal of Thrombosis and Haemostasis

  2. Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation

    Journal of Molecular and Cellular Cardiology, Vol. 37, Núm. 3, pp. 699-704

  3. Mutations in the shutter region of antithrombin result in formation of disulfide-linked dimers and severe venous thrombosis

    Journal of Thrombosis and Haemostasis, Vol. 2, Núm. 6, pp. 931-939

  4. Short alleles of P-selectin glycoprotein ligand-1 protect against premature myocardial infarction

    American Heart Journal, Vol. 148, Núm. 4, pp. 602-605

2002

  1. A common polymorphism in the annexin V Kozak sequence (-1C>T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients

    Blood, Vol. 100, Núm. 6, pp. 2081-2086